Diabetes type II: A risk factor for depression-Parkinson–Alzheimer?

Depression, chronic diseases, and decrements in health: results from the World Health Surveys

Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., & Ustun, B. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61415-9 · Cited by 4,070 · see citing works

Intracellular Aspects of the Process of Protein Synthesis

Palade, G. E. (1975) · Science · doi:10.1126/science.1096303 · Cited by 3,583 · see citing works

Diabetes mellitus and the risk of dementia: The Rotterdam Study

Ott, A., Stolk, R. P., van Harskamp, F., Pols, H. A. P., Hofman, A., & Breteler, M. M. B. (1999) · Neurology · doi:10.1212/wnl.53.9.1937 · Cited by 2,175 · see citing works

Neuroinflammation in Parkinson’s disease: A target for neuroprotection?

Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984 · see citing works

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

Brookmeyer, R., Gray, S. G., & Kawas, C. H. (1998) · American Journal of Public Health · doi:10.2105/ajph.88.9.1337 · Cited by 1,774 · see citing works

Type 2 Diabetes, APOE Gene, and the Risk for Dementia and Related Pathologies

Peila, R., Rodriguez, B. L., & Launer, L. J. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1256 · Cited by 1,207 · see citing works

Alzheimer’s disease is type 3 diabetes—Evidence reviewed

de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158 · see citing works

The stress system in the human brain in depression and neurodegeneration

Swaab, D. F., Bao, A.-M., & Lucassen, P. J. (2005) · Ageing Research Reviews · doi:10.1016/j.arr.2005.03.003 · Cited by 984 · see citing works

ER stress and neurodegenerative diseases

Lindholm, D., Wootz, H., & Korhonen, L. (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401778 · Cited by 882 · see citing works

Intranasal insulin improves cognition and modulates β-amyloid in early AD

Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Breitner, J. C. S., DeGroodt, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000265401.62434.36 · Cited by 830 · see citing works

Endoplasmic reticulum stress contributes to beta cell apoptosis in type 2 diabetes

Laybutt, D. R., Preston, A. M., Åkerfeldt, M. C., Kench, J. G., Busch, A. K., Biankin, A. V., & Biden, T. J. (2007) · Diabetologia · doi:10.1007/s00125-006-0590-z · Cited by 830 · see citing works

The question of familial meningiomas and schwannomas:

King, A. A., & Gutmann, D. H. (2000) · Neurology · doi:10.1212/wnl.54.1.4 · Cited by 814 · see citing works

Central obesity and increased risk of dementia more than three decades later

Whitmer, R. A., Gustafson, D. R., Barrett-Connor, E., Haan, M. N., Gunderson, E. P., & Yaffe, K. (2008) · Neurology · doi:10.1212/01.wnl.0000306313.89165.ef · Cited by 803 · see citing works

Brain insulin and insulin receptors in aging and sporadic Alzheimer’s disease

Frölich, L., Blum-Degen, D., Bernstein, H.-G., Engelsberger, S., Humrich, J., Laufer, S., Muschner, D., Thalheimer, A., Türk, A., Hoyer, S., et al. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050068 · Cited by 748 · see citing works

Risk of Dementia among Persons with Diabetes Mellitus: A Population-based Cohort Study

Leibson, C. L., Rocca, W. A., Hanson, V. A., Cha, R., Kokmen, E., O'Brien, P. C., & Palumbo, P. J. (1997) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009106 · Cited by 700 · see citing works

Lower cognitive function in the presence of obesity and hypertension: the Framingham heart study

Elias, M. F., Elias, P. K., SULLIVAN, L. M., Wolf, P. A., & D’Agostino, R. B. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.802225 · Cited by 691 · see citing works

Efficacy of rosiglitazone in a genetically defined population with mild-to-moderate Alzheimer’s disease

Risner, M. E., Saunders, A. M., Altman, J. F. B., Ormandy, G. C., Craft, S., Foley, I. M., Zvartau-Hind, M. E., Hosford, D. A., Roses, A. D., & for the Rosiglitazone in Alzheimer's Disease Study Group (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500369 · Cited by 686 · see citing works

Hyperinsulinemia and risk of Alzheimer disease

Luchsinger, J. A., Tang, M.-X., Shea, S., & Mayeux, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140292.04932.87 · Cited by 683 · see citing works

Association of diabetes mellitus and dementia, the Rotterdam study

Ott, A., Stolk, R. P., Hofman, A., van Harskamp, F., Grobbee, D. E., & Breteler, M. M. B. (1996) · Diabetologia · doi:10.1007/s001250050588 · Cited by 677 · see citing works

Depression, anxiety and their relationship with chronic diseases: a review of the epidemiology, risk and treatment evidence

Clarke, D. M., & Currie, K. C. (2009) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2009.tb02471.x · Cited by 661 · see citing works

Effects of intranasal insulin on cognition in memory-impaired older adults: Modulation by APOE genotype

Reger, M. A., Watson, G. S., Frey, W. H., Baker, L. D., Cholerton, B., Keeling, M. L., Belongia, D., Fishel, M. A., Plymate, S. R., Schellenberg, G. D., et al. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.03.016 · Cited by 619 · see citing works

Preserved Cognition in Patients With Early Alzheimer Disease and Amnestic Mild Cognitive Impairment During Treatment With Rosiglitazone

Watson, G. S., Cholerton, B. A., Reger, M. A., Baker, L. D., Plymate, S. R., Asthana, S., Fishel, M. A., Kulstad, J. J., Green, P. S., Cook, D. G., et al. (2005) · American Journal of Geriatric Psychiatry · doi:10.1176/appi.ajgp.13.11.950 · Cited by 607 · see citing works

Nitric oxide-induced apoptosis in pancreatic β cells is mediated by the endoplasmic reticulum stress pathway

Oyadomari, S., Takeda, K., Takiguchi, M., Gotoh, T., Matsumoto, M., Wada, I., Akira, S., Araki, E., & Mori, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191207498 · Cited by 599 · see citing works

The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function

Awad, N., Gagnon, M., & Messier, C. (2004) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803390490514875 · Cited by 551 · see citing works

Memory improvement following induced hyperinsulinemia in Alzheimer’s disease

Craft, S., Newcomer, J., Kanne, S., Dagogo-Jack, S., Cryer, P., Sheline, Y., Luby, J., Dagogo-Jack, A., & Alderson, A. (1996) · Neurobiology of Aging · doi:10.1016/0197-4580(95)02002-0 · Cited by 538 · see citing works

Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.

Lannert, H., & Hoyer, S. (1998) · Behavioral Neuroscience · doi:10.1037/0735-7044.112.5.1199 · Cited by 525 · see citing works

Depression and Advanced Complications of Diabetes

Lin, E. H. B., Rutter, C. M., Katon, W., Heckbert, S. R., Ciechanowski, P., Oliver, M. M., Ludman, E. J., Young, B. A., Williams, L. H., McCulloch, D. K., et al. (2010) · Diabetes Care · doi:10.2337/dc09-1068 · Cited by 519 · see citing works

Intranasal Insulin Administration Dose-Dependently Modulates Verbal Memory and Plasma Amyloid-β in Memory-Impaired Older Adults

Reger, M. A., Watson, G. S., Green, P. S., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Cherrier, M. M., Schellenberg, G. D., Frey, W. H., et al. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13309 · Cited by 518 · see citing works

Stimulation of β-Amyloid Precursor Protein Trafficking by Insulin Reduces Intraneuronal β-Amyloid and Requires Mitogen-Activated Protein Kinase Signaling

Gasparini, L., Gouras, G. K., Wang, R., Gross, R. S., Beal, M. F., Greengard, P., & Xu, H. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02561.2001 · Cited by 493 · see citing works

Type 2 Diabetes and the Risk of Parkinson's Disease

Hu, G., Jousilahti, P., Bidel, S., Antikainen, R., & Tuomilehto, J. (2007) · Diabetes Care · doi:10.2337/dc06-2011 · Cited by 466 · see citing works

Stress hormones: physiological stress and regulation of metabolism

Kyrou, I., & Tsigos, C. (2009) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2009.08.007 · Cited by 440 · see citing works

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease

Hoyer, S. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.02.049 · Cited by 436 · see citing works

Association between features of the insulin resistance syndrome and alzheimer's disease independently of apolipoprotein e4 phenotype: cross sectional population based study

Kuusisto, J., Koivisto, K. J., Mykkänen, L. M., Helkala, E.-L., Vanhanen, M., Hänninen, T., Kervinen, K., Kesäniemi, Y. A., Riekkinen, P. J., & Laakso, M. (1997) · BMJ · doi:10.1136/bmj.315.7115.1045 · Cited by 426 · see citing works

The Stressed CNS: When Glucocorticoids Aggravate Inflammation

Sorrells, S. F., Caso, J. R., Munhoz, C. D., & Sapolsky, R. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.09.032 · Cited by 425 · cited 1× · see citing works

Insulin receptors in the central nervous system: Localization, signalling mechanisms and functional aspects

UNGER, J., Livingston, J. H., & Moss, A. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90015-s · Cited by 403 · see citing works

Presenilins Are Enriched in Endoplasmic Reticulum Membranes Associated with Mitochondria

Área-Gómez, E., de Groof, A. J. C., Boldogh, I. R., Bird, T. D., Gibson, G. E., Koehler, C. M., Yu, W. H., Duff, K., Yaffe, M. P., Pon, L. A., et al. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090219 · Cited by 397 · see citing works

The Role of Insulin Resistance in the Pathogenesis of Alzheimer??s Disease

Watson, G. S., & Craft, S. (2003) · CNS Drugs · doi:10.2165/00023210-200317010-00003 · Cited by 396 · see citing works

Protection by pioglitazone in the MPTP model of Parkinson's disease correlates with IκBα induction and block of NFκB and iNOS activation

Dehmer, T., Heneka, M. T., Sastre, M., DICHGANS, J., & Schulz, J. B. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02210.x · Cited by 382 · see citing works

Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein

Grünblatt, E., Šalković‐Petrišić, M., Barilar, J. O., Riederer, P. F., & Hoyer, S. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04368.x · Cited by 376 · see citing works

Protective action of the peroxisome proliferator‐activated receptor‐γ agonist pioglitazone in a mouse model of Parkinson's disease

Breidert, T., Callebert, J., Heneka, M. T., Landreth, G. E., Launay, J., & Hirsch, É. C. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00990.x · Cited by 375 · see citing works

NIDDM and Blood Pressure as Risk Factors for Poor Cognitive Performance: The Framingham Study

Elias, P. K., Elias, M. F., D'Agostino, R. B., Cupples, L. A., Wilson, P. W., Silbershatz, H., & Wolf, P. A. (1997) · Diabetes Care · doi:10.2337/diacare.20.9.1388 · Cited by 368 · see citing works

Intracerebroventricular insulin enhances memory in a passive-avoidance task

Park, C. R., Seeley, R. J., Craft, S., & WOODS, S. (2000) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00220-6 · Cited by 343 · see citing works

The dysregulation of intracellular calcium in Alzheimer disease

Supnet, C. B., & Борисович, Б. И. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.014 · Cited by 324 · see citing works

The neuroendocrinology of depression and chronic stress

Checkley, S. (1996) · British Medical Bulletin · doi:10.1093/oxfordjournals.bmb.a011570 · Cited by 323 · see citing works

Inflammation induces mitochondrial dysfunction and dopaminergic neurodegeneration in the nigrostriatal system

Hunter, R. L., Dragicevic, N., Seifert, K., Choi, D. Y., Liu, M., Kim, H., Cass, W. A., Sullivan, P. G., & Bing, G. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04327.x · Cited by 322 · see citing works

Insulin and the Blood-Brain Barrier

Woods, S. C., Seeley, R. J., Baskin, D. G., & Schwartz, M. W. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033455323 · Cited by 321 · see citing works

Neuropathological staging of Alzheimer lesions and intellectual status in Alzheimer's and Parkinson's disease patients.

Bancher, C., Braak, H., Fischer, P., & Jellinger, K. (1993) · Neuroscience Letters · doi:10.1016/0304-3940(93)90590-h · Cited by 314 · see citing works

Enhancement of Memory in Alzheimer Disease With Insulin and Somatostatin, but Not Glucose

Craft, S., Asthana, S., Newcomer, J. W., Wilkinson, C. W., Matos, I. T., Baker, L. D., Cherrier, M., Lofgreen, C., Latendresse, S., Petrova, A., et al. (1999) · Archives of General Psychiatry · doi:10.1001/archpsyc.56.12.1135 · Cited by 312 · see citing works

Enhanced Risk for Alzheimer Disease in Persons With Type 2 Diabetes and APOE ε4

Irie, F., Fitzpatrick, A. L., López, O. L., Kuller, L. H., Peila, R., Newman, A. B., & Launer, L. J. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.29 · Cited by 304 · see citing works

The influence of microglia on the pathogenesis of Parkinson's disease

Long-Smith, C. M., Sullivan, A. M., & Nolan, Y. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.08.001 · Cited by 296 · see citing works

Impaired ERAD and ER stress are early and specific events in polyglutamine toxicityPreprint

Duennwald, M. L., & Lindquist, S. L. (2008) · Genes & Development · doi:10.1101/gad.1673408 · Cited by 296 · see citing works

Cascading effects of stressors and inflammatory immune system activation: Implications for major depressive disorder

Anisman, H. (2009) · Journal of Psychiatry and Neuroscience · doi:10.1139/jpn.0902 · Cited by 292 · see citing works

Calcium dysregulation in amyotrophic lateral sclerosis

Großkreutz, J., Bosch, L. V. D., & Keller, B. U. (2010) · Cell Calcium · doi:10.1016/j.ceca.2009.12.002 · Cited by 284 · see citing works

PPARγ Agonists as Therapeutics for the Treatment of Alzheimer's Disease

Landreth, G. E., Jiang, Q., Mandrekar, S., & Heneka, M. T. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.003 · Cited by 277 · see citing works

Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis

Hoyer, S. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050067 · Cited by 265 · see citing works

Insulin increases CSF Aβ42 levels in normal older adults

Watson, G. S., Peskind, E. R., Asthana, S., Purganan, K., Wait, C., Chapman, D., Schwartz, M. W., Plymate, S. R., & Craft, S. (2003) · Neurology · doi:10.1212/01.wnl.0000065916.25128.25 · Cited by 265 · see citing works

Experimental diabetes in rats causes hippocampal dendritic and synaptic reorganization and increased glucocorticoid reactivity to stress

Magariños, A. M., & McEwen, B. S. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.20.11056 · Cited by 262 · see citing works

Frequency of dementia, depression, and other neuropsychiatric symptoms in 1,449 outpatients with Parkinson's disease

Riedel, O., Klotsche, J., Spottke, A., Deuschl, G., Förstl, H., Henn, F., Heuser, I., Oertel, W., Reichmann, H., Riederer, P., et al. (2010) · Journal of Neurology · doi:10.1007/s00415-010-5465-z · Cited by 256 · see citing works

Insulin dose–response effects on memory and plasma amyloid precursor protein in Alzheimer’s disease: interactions with apolipoprotein E genotype

Craft, S., Asthana, S., Cook, D. G., Baker, L. D., Cherrier, M. M., Purganan, K., Wait, C., Petrova, A., Latendresse, S. J., Watson, G. S., et al. (2003) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(02)00087-2 · Cited by 255 · see citing works

Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach

Salkovic-Petrisic, M., & Hoyer, S. (2007) · Springer eBooks · doi:10.1007/978-3-211-73574-9_28 · Cited by 249 · see citing works

Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study

Hassing, L. B. (2004) · Age and Ageing · doi:10.1093/ageing/afh100 · Cited by 249 · see citing works

Nitrosamine Exposure Causes Insulin Resistance Diseases: Relevance to Type 2 Diabetes Mellitus, Non-Alcoholic Steatohepatitis, and Alzheimer's Disease

Tong, M., Neusner, A. D., Longato, L., Lawton, M., Wands, J. R., & de la Monte, S. M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1115 · Cited by 247 · see citing works

The Relationship Between Diabetes Mellitus and Parkinson'S Disease

Sandyk, R. (1993) · International Journal of Neuroscience · doi:10.3109/00207459309003322 · Cited by 244 · see citing works

Degradation of Soluble Amyloid β-Peptides 1–40, 1–42, and the Dutch Variant 1–40Q by Insulin Degrading Enzyme from Alzheimer Disease and Control Brains

Pérez, A., Morelli, L., Cresto, J. C., & Castaño, E. M. (2000) · Neurochemical Research · doi:10.1023/a:1007527721160 · Cited by 240 · see citing works

Impaired insulin secretion increases the risk of Alzheimer disease

Rönnemaa, E., Zethelius, B., Sundelöf, J. E., Sundström, J., Degerman-Gunnarsson, M., Berne, C., Lannfelt, L., & Kilander, L. (2008) · Neurology · doi:10.1212/01.wnl.0000310646.32212.3a · Cited by 240 · see citing works

The psychoneuroimmunology of depression

Leonard, B. E., & Myint, A.-M. (2009) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1011 · Cited by 236 · see citing works

Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease

Simon, K. C., Chen, H., Schwarzschild, M. A., & Ascherio, A. (2007) · Neurology · doi:10.1212/01.wnl.0000271883.45010.8a · Cited by 231 · see citing works

Altered cerebral energy metabolism in Alzheimer's disease: a PET study.

Fukuyama, H., Ogawa, M., Yamauchi, H., Yamaguchi, S., Kimura, J., Yonekura, Y., & Konishi, J. (1994) · PubMed · Cited by 228 · see citing works

A Review of the Evidence for a Neuroendocrine Link Between Stress, Depression and Diabetes Mellitus

Golden, S. H. (2007) · Current Diabetes Reviews · doi:10.2174/157339907782330021 · Cited by 224 · see citing works

Studies on Streptozotocin Diabetes

Ganda, O. P., Rossini, A. A., & Like, A. A. (1976) · Diabetes · doi:10.2337/diab.25.7.595 · Cited by 224 · see citing works

Alzheimer‐like changes in protein kinase B and glycogen synthase kinase‐3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathway

Šalković‐Petrišić, M., Tribl, F., Schmidt, M., Hoyer, S., & Riederer, P. F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03637.x · Cited by 223 · see citing works

PET studies in dementia

Herholz, K. (2003) · Annals of Nuclear Medicine · doi:10.1007/bf02988444 · Cited by 217 · see citing works

Adiposity, Type 2 Diabetes, and Alzheimer's Disease

Luchsinger, J. A., & Gustafson, D. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1022 · Cited by 212 · see citing works

The cellular and physiological actions of insulin in the central nervous system

Wozniak, M., Rydzewski, B. Z., Baker, S. P., & Raizada, M. K. (1993) · Neurochemistry International · doi:10.1016/0197-0186(93)90062-a · Cited by 207 · see citing works

Effects of Environmental Stress and Gender on Associations among Symptoms of Depression and the Serotonin Transporter Gene Linked Polymorphic Region (5-HTTLPR)

Brummett, B. H., Boyle, S. H., Siegler, I. C., Kuhn, C. M., Ashley-Koch, A., Jonassaint, C. R., Züchner, S., Collins, A., & Williams, R. B. (2008) · Behavior Genetics · doi:10.1007/s10519-007-9172-1 · Cited by 201 · see citing works

Nigral and extranigral pathology in Parkinson's disease.

Braak, H., Braak, E., Yilmazer‐Hanke, D., Schultz, C., de Vos, R. A. I., & Jansen, E. N. H. (1995) · PubMed · Cited by 198 · see citing works

Overweight in midlife and risk of dementia: a 40-year follow-up study

Hassing, L. B., Dahl, A. K., Thorvaldsson, V, Berg, S., Gatz, M., Pedersen, N. L., & Johansson, B. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.104 · Cited by 197 · see citing works

Type 2 diabetes and risk of cognitive impairment and dementia

Whitmer, R. A. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0058-7 · Cited by 195 · see citing works

Depression and dementia

Korczyn, A. D., & Halperin, I. J. Y. (2009) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2009.02.346 · Cited by 182 · see citing works

Type 2 diabetes mellitus contributes to cognitive decline in old age: A longitudinal population-based study

Hassing, L. B., GRANT, M. D., Hofer, S. M., Pedersen, N. L., NILSSON, S. E., Berg, S., McClearn, G. E., & Johansson, B. E. A. (2004) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617704104165 · Cited by 182 · see citing works

Insulin resistance and hippocampal volume in women at risk for Alzheimer's disease

Rasgon, N., Kenna, H. A., Wroolie, T., Kelley, R. G., Silverman, D. H. S., Brooks, J. O., Williams, K. E., Powers, B. N., Hallmayer, J. F., & Reiss, A. L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.005 · Cited by 180 · see citing works

Amyloid-Associated Depression: A Prodromal Depression of Alzheimer Disease?

Sun, X., Steffens, D. C., Au, R., Folstein, M., Summergrad, P., Yee, J., Rosenberg, I., Mwamburi, D. M., & Qiu, W. Q. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.5.542 · Cited by 174 · see citing works

Prospective Cohort Study of Type 2 Diabetes and the Risk of Parkinson's Disease

Driver, J. A., Smith, A., Buring, J. E., Gaziano, J. M., Kurth, T., & Logroscino, G. (2008) · Diabetes Care · doi:10.2337/dc08-0688 · Cited by 168 · see citing works

The Role of Insulin, Insulin Growth Factor, and Insulin‐Degrading Enzyme in Brain Aging and Alzheimer′s Disease

Messier, C., & Teutenberg, K. (2005) · Neural Plasticity · doi:10.1155/np.2005.311 · Cited by 168 · see citing works

Rrs1 Is Involved in Endoplasmic Reticulum Stress Response in Huntington Disease

Carnemolla, A., Fossale, E., Agostoni, E., Michelazzi, S., Calligaris, R., Maso, L. D., Sal, G. D., MacDonald, M. E., & Persichetti, F. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.018325 · Cited by 164 · see citing works

A Disturbance in the Neuronal Insulin Receptor Signal Transduction in Sporadic Alzheimer's Disease

Frölich, L., Blum-Degen, D., Riederer, P. F., & Hoyer, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07839.x · Cited by 160 · see citing works

Is late onset depression a prodrome to dementia?

Schweitzer, I., Tuckwell, V., O'Brien, J. T., & Ames, D. J. (2002) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.525 · Cited by 160 · see citing works

Intracerebroventricular injection of streptozotocin causes neurotoxicity to myelin that contributes to spatial memory deficits in rats

Shoham, S., Bejar, C., Kovalev, E., & Weinstock, M. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.08.015 · Cited by 152 · see citing works

Loss of insulin receptor immunoreactivity from the substantia nigra pars compacta neurons in Parkinson's disease

Moroo, I., Yamada, T., Makino, H., Tooyama, I., McGeer, P., Mcgeer, E., & Hirayama, K. (1994) · Acta Neuropathologica · doi:10.1007/bf00313602 · Cited by 149 · see citing works

PPAR: a therapeutic target in Parkinson’s disease

Chaturvedi, R. K., & Beal, M. F. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05388.x · Cited by 147 · see citing works

The endoplasmic reticulum: integration of protein folding, quality control, signaling and degradation

Chevet, É., Cameron, P. H., Pelletier, M. F., Thomas, D. Y., & Bergeron, J. J. M. (2001) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(00)00168-8 · Cited by 143 · see citing works

The pre-morbid personality of patients with Parkinson's disease.

Todes, C., & Lees, A. J. (1985) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.48.2.97 · Cited by 135 · see citing works

Deletion of Irs2 reduces amyloid deposition and rescues behavioural deficits in APP transgenic mice

Killick, R., Scales, G., Leroy, K., Čaušević, M., Hooper, C., Irvine, E. E., Choudhury, A. I., Drinkwater, L., Kerr, F., Al‐Qassab, H., et al. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.032 · Cited by 132 · see citing works

Metabolic syndrome, mild cognitive impairment, and progression to dementia. The Italian Longitudinal Study on Aging

Solfrizzi, V., Scafato, E., Capurso, C. A., D’Introno, A., Colacicco, A. M., Frisardi, V., Vendemiale, G., Baldereschi, M., Crepaldi, G., Carlo, A. D., et al. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2009.12.012 · Cited by 131 · see citing works

Insulin receptor mRNA in the substantia nigra in Parkinson's disease.

Takahashi, M., Yamada, T., Tooyama, I., Moroo, I., Kimura, H., Yamamoto, T., & Okada, H. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12357-0 · Cited by 131 · see citing works

Innate and Adaptive Immunity for the Pathobiology of Parkinson's Disease

Stone, D. K., Reynolds, A. D., Mosley, R. L., & Gendelman, H. E. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2460 · Cited by 130 · see citing works

Diabetes trends in Europe

Passa, P. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.276 · Cited by 127 · see citing works

Metabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap

McIntyre, R. S., Rasgon, N. L., Kemp, D. E., Nguyen, H. T., Law, C. W. Y., Taylor, V. H., Woldeyohannes, H. O., Alsuwaidan, M. T., Soczynska, J. K., Kim, B., et al. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0010-0 · Cited by 127 · see citing works

The PPARγ agonist pioglitazone is effective in the MPTP mouse model of Parkinson's disease through inhibition of monoamine oxidase B

Quinn, L. P., Crook, B., Hows, M. E. P., Vidgeon-Hart, M., Chapman, H., Upton, N., Medhurst, A. D., & Virley, D. J. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.78 · Cited by 120 · see citing works

Insulin-Resistant Brain State after Intracerebroventricular Streptozotocin Injection Exacerbates Alzheimer-like Changes in Tg2576 AβPP-Overexpressing Mice

Plaschke, K., Kopitz, J., Siegelin, M., Schliebs, R., Salkovic-Petrisic, M., Riederer, P., & Hoyer, S. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1270 · Cited by 118 · cited 1× · see citing works

Neuropsychological and perceptual defects in Parkinson's disease

Bodis-Wollner, I. G. (2003) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(03)00022-1 · Cited by 118 · see citing works

Genes, stress, and depression

Wurtman, R. J. (2005) · Metabolism · doi:10.1016/j.metabol.2005.01.007 · Cited by 109 · see citing works

Beneficial effects of pioglitazone on cognitive impairment in MPTP model of Parkinson's disease

Kumar, P., Kaundal, R. K., More, S. V., & Sharma, S. S. (2008) · Behavioural Brain Research · doi:10.1016/j.bbr.2008.10.010 · Cited by 105 · see citing works

Desensitization of brain insulin receptor Effect on glucose/energy and related metabolism

Hoyer, S., Müller, D., & Plaschke, K. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9350-1_20 · Cited by 104 · see citing works

Biomarkers for the Early Detection of Parkinson’s and Alzheimer’s Disease

Berg, D. (2008) · Neurodegenerative Diseases · doi:10.1159/000113682 · Cited by 103 · see citing works

Cognitive Functioning and Brain MRI in Patients with Type 1 and Type 2 Diabetes Mellitus: A Comparative Study

Brands, A. M. A., Biessels, G. J., Kappelle, L. J., de Haan, E. H. F., de Valk, H. W., Algra, A., & Kessels, R. P. C. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000100980 · Cited by 103 · see citing works

Damaged neuronal energy metabolism and behavior are improved by Ginkgo biloba extract (EGb 761)

Hoyer, S., Lannert, H., Nöldner, M., & Chatterjee, S. S. (1999) · Journal of Neural Transmission · doi:10.1007/s007020050232 · Cited by 102 · see citing works

Distribution of insulin receptor substrate-2 in brain areas involved in energy homeostasis

Pardini, A. W., Hồng, N. T., Figlewicz, D. P., Baskin, D. G., Williams, D. L., Kim, F., & Schwartz, M. W. (2006) · Brain Research · doi:10.1016/j.brainres.2006.06.109 · Cited by 101 · see citing works

Mechanisms of Nitrosamine-Mediated Neurodegeneration: Potential Relevance to Sporadic Alzheimer's Disease

de la Monte, S. M., & Tong, M. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1098 · Cited by 98 · see citing works

Cortisol is higher in parkinsonism and associated with gait deficit

Charlett, A., Dobbs, R. J., Purkiss, A. G., Wrighe, D. J., Peterson, D. W., Weller, C., & Dobbs, S. M. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1998.tb00614.x · Cited by 98 · see citing works

Sex differences in the hypothalamus in the different stages of human life

Swaab, D. F., Chung, W. C. J., Kruijver, F. P. M., Hofman, M. A., & Hestiantoro, A. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00059-9 · Cited by 97 · see citing works

Diabetes mellitus and progression of rigidity and gait disturbance in older persons

Arvanitakis, Z., Wilson, R. S., Schneider, J. A., Bienias, J. L., Evans, D. A., & Bennett, D. A. (2004) · Neurology · doi:10.1212/01.wnl.0000138432.16676.4b · Cited by 97 · see citing works

Towards a pathway definition of Parkinson’s disease: a complex disorder with links to cancer, diabetes and inflammation

Moran, L. B., & Graeber, M. B. (2008) · Neurogenetics · doi:10.1007/s10048-007-0116-y · Cited by 95 · see citing works

Do early-life insults contribute to the late-life development of Parkinson and Alzheimer diseases?

Miller, D. B., & O'Callaghan, J. P. (2008) · Metabolism · doi:10.1016/j.metabol.2008.07.011 · Cited by 93 · see citing works

Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: Relevance to Parkinson's disease

Arduíno, D. M., Esteves, A. R., Cardoso, S. M., & Oliveira, C. R. (2009) · Neurochemistry International · doi:10.1016/j.neuint.2009.04.004 · Cited by 92 · see citing works

The Relation between Apolipoprotein A-I and Dementia: The Honolulu-Asia Aging Study

Saczynski, J. S., White, L. R., Peila, R., Rodríguez, B. L., & Launer, L. J. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm027 · Cited by 92 · see citing works

The effect of intrahippocampal insulin microinjection on spatial learning and memory

Moosavi, M., Naghdi, N., Maghsoudi, N., & Zahediasl, S. (2006) · Hormones and Behavior · doi:10.1016/j.yhbeh.2006.06.025 · Cited by 91 · see citing works

Transport of calcium in the perfused submandibular gland of the cat

Nielsen, S. P., & Petersen, O. H. (1972) · The Journal of Physiology · doi:10.1113/jphysiol.1972.sp009869 · Cited by 90 · see citing works

Insulin-responsive glucose transporters—GLUT8 and GLUT4 are expressed in the developing mammalian brain

Sankar, R., Thamotharan, S., Shin, D. H., Moley, K. H., & Devaskar, S. U. (2002) · Molecular Brain Research · doi:10.1016/s0169-328x(02)00487-4 · Cited by 88 · see citing works

Inhibition of the Neuronal Insulin Receptor An in Vivo Model for Sporadic Alzheimer Disease?

Hoyer, S., Lee, S. K., Löffler, T., & Schliebs, R. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06932.x · Cited by 87 · see citing works

Occurrence Risk and Structure of Depression in Parkinson Disease With and Without Dementia: Results From the GEPAD Study

Riedel, O., Heuser, I., Klotsche, J., Dodel, R., & Wittchen, H. (2010) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988709351833 · Cited by 87 · see citing works

Inhibition of the Neuronal Insulin Receptor Causes Alzheimer‐like Disturbances in Oxidative/Energy Brain Metabolism and in Behavior in Adult Rats

Hoyer, S., & Lannert, H. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07842.x · Cited by 87 · see citing works

Nitrosamine exposure exacerbates high fat diet-mediated type 2 diabetes mellitus, non-alcoholic steatohepatitis, and neurodegeneration with cognitive impairment

de la Monte, S. M., Tong, M., Lawton, M., & Longato, L. (2009) · Molecular Neurodegeneration · doi:10.1186/1750-1326-4-54 · Cited by 87 · see citing works

Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons

Brodbeck, J., Balestra, M. E., Saunders, A. M., Roses, A. D., Mahley, R. W., & Huang, Y. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709906104 · Cited by 86 · see citing works

Diabetes and brain aging: Epidemiologic evidence

Launer, L. J. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0069-1 · Cited by 85 · see citing works

Apolipoprotein E4 Domain Interaction Induces Endoplasmic Reticulum Stress and Impairs Astrocyte Function

Zhong, N., Ramaswamy, G., & Weisgraber, K. H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.014464 · Cited by 85 · see citing works

Die Parkinson-Krankheit

Berg, D., & Riederer, P. F. (2004) · Springer eBooks · doi:10.1007/978-3-642-18741-4_8 · Cited by 83 · see citing works

Induction of Endoplasmic Reticulum Stress in Retinal Pericytes by Glucose Deprivation

Ikesugi, K., Mulhern, M. L., Madson, C. J., Hosoya, K., Terasaki, T., Kador, P. F., & Shinohara, T. (2006) · Current Eye Research · doi:10.1080/02713680600966785 · Cited by 83 · see citing works

Brain metabolic decreases related to the dose of the ApoE e4 allele in Alzheimer's disease

Mosconi, L. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.014993 · Cited by 83 · see citing works

Intrahippocampal insulin improves memory in a passive-avoidance task in male wistar rats

Babri, S., Pourbadie, H. G., Khamenei, S., & Seydlar, M. O. (2007) · Brain and Cognition · doi:10.1016/j.bandc.2007.01.002 · Cited by 79 · see citing works

Endoplasmic reticulum stress and diabetic retinopathy

Oshitari, T. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.2008.04.01.115 · Cited by 79 · see citing works

Alzheimer Lesions in the Entorhinal Region and Isocortex in Parkinson's and Alzheimer's Diseasesa

Jellinger, K. A., Braak, H., Braak, E., & Fischer, P. A. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb00218.x · Cited by 79 · see citing works

Appointments

(1975) · Science · doi:10.1126/science.189.4206.867-b · Cited by 78 · see citing works

Metabolic interaction between ApoE genotype and onset age in Alzheimer's disease: implications for brain reserve

Mosconi, L. (2004) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.030882 · Cited by 76 · see citing works

Homocysteine-induced endoplasmic reticulum protein (herp) is up-regulated in parkinsonian substantia nigra and present in the core of Lewy bodies.

Słodziński, H., Moran, L. B., Michael, G. J., Wang, B., Novoselov, S. S., Cheetham, M. E., Pearce, R. K. B., & Graeber, M. B. (2009) · PubMed · Cited by 75 · see citing works

Insulin effects on CSF norepinephrine and cognition in Alzheimer's disease

Watson, G. S., Bernhardt, T., Reger, M. A., Cholerton, B., Baker, L. D., Peskind, E. R., Asthana, S., Plymate, S. R., Frölich, L., & Craft, S. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.11.011 · Cited by 75 · see citing works

Diabetes in Patients With Idiopathic Parkinson's Disease

Becker, C., Brobert, G., Johansson, S., Jick, S. S., & Meier, C. R. (2008) · Diabetes Care · doi:10.2337/dc08-0479 · Cited by 75 · see citing works

Peroxisome Proliferator-Activated Receptor (PPAR)β /δ: A New Potential Therapeutic Target for the Treatment of Metabolic Syndrome

Coll, T., Rodríguez‐Calvo, R., Barroso, E., Serrano, L., Eyre, E., Palomer, X., & Vázquez‐Carrera, M. (2009) · Current Molecular Pharmacology · doi:10.2174/1874467210902010046 · Cited by 75 · see citing works

Diabetes preceding Parkinson's disease onset. A case–control study

D’Amelio, M., Ragonese, P., Callari, G., Benedetto, N. D., Palmeri, B., Terruso, V., Salemi, G., Famoso, G., Aridon, P., & Savettieri, G. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.02.013 · Cited by 74 · see citing works

Symptoms of depression but not anxiety are associated with central obesity and cardiovascular disease in people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study

on behalf of the Edinburgh Type 2 Diabetes Study Investigators, Labad, J., Price, J. F., Strachan, M. W. J., Fowkes, F. G. R., Ding, J., Deary, I. J., Lee, A. J., Frier, B. M., Seckl, J. R., et al. (2009) · Diabetologia · doi:10.1007/s00125-009-1628-9 · Cited by 71 · see citing works

Performance of FDG PET for Detection of Alzheimer’s Disease in Two Independent Multicentre Samples (NEST-DD and ADNI)

Haense, C., Herholz, K., Jagust, W., & Heiss, W. (2009) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000241879 · Cited by 69 · see citing works

Relationship Between Cortisol Levels and Memory Performance may be Modulated by the Presence or Absence of Cognitive Impairment: Evidence from Healthy Elderly, Mild Cognitive Impairment and Alzheimer's Disease Subjects

Souza‐Talarico, J. N., Chaves, E. C., LUPIEN, S. J., Nitríni, R., & Caramelli, P. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1282 · Cited by 67 · see citing works

Glucose metabolism and the risk of Alzheimer’s disease and dementia: a population-based 12 year follow-up study in 71-year-old men

Rönnemaa, E., Zethelius, B., Sundelöf, J. E., Sundström, J., Degerman-Gunnarsson, M., Lannfelt, L., Berne, C., & Kilander, L. (2009) · Diabetologia · doi:10.1007/s00125-009-1393-9 · Cited by 66 · see citing works

Rethinking the central causes of diabetes

Elmquist, J. K., & Marcus, J. (2003) · Nature Medicine · doi:10.1038/nm0603-645 · Cited by 65 · see citing works

Regulation of β-amyloid levels in the brain of cholesterol-fed rabbit, a model system for sporadic Alzheimer’s disease

Prasanthi, R., Schommer, E., Thomasson, S., Thompson, A. J., Feist, G., & Ghribi, O. (2008) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2008.09.002 · Cited by 65 · see citing works

Gene expression profile in streptozotocin rat model for sporadic Alzheimer?s disease

Grünblatt, E., Hoyer, S., & Riederer, P. F. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-003-0030-x · Cited by 63 · see citing works

Does depression increase the risk of developing type 2 diabetes?

Cosgrove, M., Sargeant, L. A., & Griffin, S. J. (2007) · Occupational Medicine · doi:10.1093/occmed/kqm105 · Cited by 61 · see citing works

Effects of insulin on long-term potentiation in hippocampal slices from diabetic rats

Izumi, Y., Yamada, K. A., Matsukawa, M., & Zorumski, C. F. (2003) · Diabetologia · doi:10.1007/s00125-003-1144-2 · Cited by 60 · see citing works

Genetic risk factors and markers for Alzheimer’s disease and/or depression in the VITA study

Grünblatt, E., Zehetmayer, S., Bartl, J., Löffler, C., Wichart, I., Rainer, M. K., Jungwirth, S., Bauer, P., Danielczyk, W., Tragl, K., et al. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2008.05.008 · Cited by 57 · see citing works

Altered regulation of brain glucose metabolism as a cause of neurodegenerative disorders?

Blum-Degen, D., Frölich, L., Hoyer, S., & Riederer, P. F. (1995) · PubMed · Cited by 55 · see citing works

Increased body mass and depressive symptomatology are associated with hypercholesterolemia, among elderly individuals; results from the MEDIS study

Tyrovolas, S., Lionis, C. D., Zeimbekis, A., Bountziouka, V. P., Micheli, M., Katsarou, A. L., Papairakleous, N., Metallinos, G., Makri, K., Polychronopoulos, E., et al. (2009) · Lipids in Health and Disease · doi:10.1186/1476-511x-8-10 · Cited by 55 · see citing works

Diabetes and Parkinsonian Signs in Older Persons

Arvanitakis, Z., Wilson, R. S., Bienias, J. L., & Bennett, D. A. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31805ba768 · Cited by 54 · see citing works

Intranasal insulin administration: A method for dissociating central and peripheral effects of insulin

Reger, M. A., & Craft, S. (2006) · Drugs of today · doi:10.1358/dot.2006.42.11.1007675 · Cited by 53 · see citing works

Excitotoxicity and Oxidative Stress during Inhibition of Energy Metabolism

Zeevalk, G. D., Bernard, L. P., Sinha, C., Ehrhart, J., & Nicklas, W. J. (1998) · Developmental Neuroscience · doi:10.1159/000017342 · Cited by 49 · see citing works

Effect of Streptozotocin‐Induced Diabetes on Rat Brain Mitochondria

Moreira, P. I., Santos, M. S., Moreno, A. M., Proença, T., Seiça, R., & Oliveira, C. R. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.1107.x · Cited by 47 · see citing works

Stress: the shared common component in major mental illnesses

Dinan, T. G. (2005) · European Psychiatry · doi:10.1016/s0924-9338(05)80184-1 · Cited by 45 · see citing works

Models of Alzheimer’s disease: cellular and molecular aspects

Hoyer, S. (1997) · Springer eBooks · doi:10.1007/978-3-7091-6844-8_2 · Cited by 43 · see citing works

INTRANASAL INSULIN IMPROVES COGNITION AND MODULATES β-AMYLOID IN EARLY AD

Dhamoon, M. S., & Noble, J. M. (2009) · Neurology · doi:10.1212/01.wnl.0000344246.91081.2c · Cited by 43 · see citing works

Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat

Grünblatt, E., Koutsilieri, E., Hoyer, S., & Riederer, P. F. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9305 · Cited by 38 · see citing works

Insulin Resistance and Cognitive Impairment

Craft, S. (2005) · Archives of Neurology · doi:10.1001/archneur.62.7.1043-a · Cited by 35 · see citing works

Endoplasmic reticulum stress and diabetic retinopathy

Oshitari, T. (2008) · Vascular Health and Risk Management · doi:10.2147/vhrm.s2293 · Cited by 31 · see citing works

Chronic exogenous corticosterone administration generates an insulin-resistant brain state in rats

Barilar, J. O., Plaschke, K., Šalković‐Petrišić, M., Grünblatt, E., Riederer, P. F., & Hoyer, S. (2009) · Stress · doi:10.3109/10253890903080379 · Cited by 28 · see citing works

α-Synuclein and LRRK2: Partners in Crime

Tong, Y., & Shen, J. (2009) · Neuron · doi:10.1016/j.neuron.2009.12.017 · Cited by 25 · see citing works

Acute levodopa administration reduces cortisol release in patients with Parkinson’s disease

Müller, T. H., Welnic, J., & Muhlack, S. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-006-0552-0 · Cited by 25 · see citing works

The comorbidity of diabetes mellitus and psychiatric disorders.

Medved, V., Jovanović, N., & Knapić, V. P. (2009) · PubMed · Cited by 25 · see citing works

The Effects of Stress and the Results of Medication in Different Personalities with Parkinsonʼs Disease

PRICHARD, J. S., Schwab, R. S., & TILLMANN, W. A. (1951) · Psychosomatic Medicine · doi:10.1097/00006842-195103000-00003 · Cited by 22 · see citing works

Intracerebroventricular administration of betacytotoxics alters expression of brain monoamine transporter genes

Šalković-Petrišić, M., & Lacković, Z. (2003) · Journal of Neural Transmission · doi:10.1007/s00702-002-0773-9 · Cited by 21 · see citing works

The interaction between acute oligomer Aβ1–40 and stress severely impaired spatial learning and memory

Huang, H.-J., Liang, K., Chang, Y.-Y., Ke, H.-C., Lin, J.-Y., & Hsieh‐Li, H. M. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2009.07.010 · Cited by 18 · see citing works

Diabetes and the Brain

Biessels, G. J., & Luchsinger, J. A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-850-8 · Cited by 17 · see citing works

Commonalities in the genetics of Alzheimer’s disease and Parkinson’s disease

Grünblatt, E. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.12.1865 · Cited by 14 · see citing works

INTRANASAL INSULIN IMPROVES COGNITION AND MODULATES β-AMYLOID IN EARLY AD

Djupesland, P. G. (2008) · Neurology · doi:10.1212/01.wnl.0000327291.47162.ed · Cited by 12 · see citing works

Impact of endurance exercise on levodopa-associated cortisol release and force increase in patients with Parkinson’s disease

Müller, T. H., & Muhlack, S. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0018-7 · Cited by 11 · see citing works

Cognition in Type 2 Diabetes or Pre-diabetic Stages

van den Berg, E., Reijmer, Y. D., & Biessels, G. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-850-8_12 · Cited by 7 · see citing works

Cognition in Children and Adolescents with Type 1 Diabetes

Ryan, C. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-850-8_10 · Cited by 6 · see citing works

Cognition in Adults with Type 1 Diabetes

Brands, A. M. A., Kessels, R. P. C., & Ryan, C. M. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-850-8_11 · Cited by 5 · see citing works

Type 2 Diabetes, Related Conditions, and Dementia

Luchsinger, J. A. (2009) · Humana Press eBooks · doi:10.1007/978-1-60327-850-8_13 · Cited by 5 · see citing works

Diabetes and depression--is there a link to the HPA axis?

Alexander, A. (2008) · Occupational Medicine · doi:10.1093/occmed/kqn041 · Cited by 4 · see citing works

Untitled work

(1998) · doi:10.1002/(sici)1096-9861(19981005)399:4

BDNF mediates adaptive brain and body responses to energetic challenges

Marosi, K., & Mattson, M. P. (2014) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2013.10.006 · Cited by 568 · see citing works

The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease

Ferreira, S. T., & Klein, W. L. (2011) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2011.08.003 · Cited by 442 · see citing works

Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin

Hsu, C.-C., Wahlqvist, M. L., Lee, M.-S., & Tsai, H.-N. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101524 · Cited by 372 · see citing works

How does brain insulin resistance develop in Alzheimer's disease?

De Felice, F. G., Lourenco, M. V., & Ferreira, S. T. (2014) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2013.12.004 · Cited by 337 · see citing works

The Diabetes Drug Liraglutide Ameliorates Aberrant Insulin Receptor Localisation and Signalling in Parallel with Decreasing Both Amyloid-β Plaque and Glial Pathology in a Mouse Model of Alzheimer’s Disease

Long-Smith, C. M., Manning, S., McClean, P. L., Coakley, M. F., O’Halloran, D., Hölscher, C., & O’Neill, C. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8199-5 · Cited by 156 · see citing works

Sleep Disturbances in Alzheimer’s and Parkinson’s Diseases

Rothman, S. M., & Mattson, M. P. (2012) · NeuroMolecular Medicine · doi:10.1007/s12017-012-8181-2 · Cited by 102 · see citing works

Insulin Has Multiple Antiamyloidogenic Effects on Human Neuronal Cells

Pandini, G., Pace, V., Copani, A., Squatrito, S., Milardi, D., & Vigneri, R. (2012) · Endocrinology · doi:10.1210/en.2012-1661 · Cited by 96 · see citing works

Long-Term Corticosterone Exposure Decreases Insulin Sensitivity and Induces Depressive-Like Behaviour in the C57BL/6NCrl Mouse

van Donkelaar, E. L., Vaessen, K. R. D., Pawluski, J. L., Sierksma, A. S. R., Blokland, A., Cañete, R., & Steinbusch, H. W. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106960 · Cited by 66 · see citing works

NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice

Salehi-Sadaghiani, M., Paydar, M. J., Gharedaghi, M. H., Zandieh, A., Heydarpour, P., Yousefzadeh-fard, Y., & Dehpour, A. R. (2012) · Psychopharmacology · doi:10.1007/s00213-012-2722-0 · Cited by 65 · see citing works

Migraine, Brain Glucose Metabolism and the “Neuroenergetic” Hypothesis: A Scoping Review

Moro, L. D., Rota, E., Pirovano, E., & Rainero, I. (2022) · Journal of Pain · doi:10.1016/j.jpain.2022.02.006 · Cited by 64 · see citing works

Exposure to pesticides and the prevalence of diabetes in a rural population in Korea

Park, S., Kim, S.-K., Kim, J.-Y., Lee, K., Choi, J. R., Chang, S. J., Chung, C. H., Park, K., Oh, S., & Koh, S. B. (2018) · NeuroToxicology · doi:10.1016/j.neuro.2018.10.007 · Cited by 59 · see citing works

Parkinson and depression: review and outlook

Laux, G. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02456-3 · Cited by 52 · see citing works

The effect of rosiglitazone on LRP1 expression and amyloid β uptake in human brain microvascular endothelial cells: a possible role of a low-dose thiazolidinedione for dementia treatment

Moon, J. H., Kim, H. J., Yang, A. H., Kim, H. M., Lee, B., Kang, E. S., Lee, H. C., & Soo, B. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711001611 · Cited by 47 · see citing works

Long Term Exendin-4 Treatment Reduces Food Intake and Body Weight and Alters Expression of Brain Homeostatic and Reward Markers

Yang, Y., Moghadam, A. A., Cordner, Z. A., Liang, N., & Moran, T. H. (2014) · Endocrinology · doi:10.1210/en.2014-1052 · Cited by 46 · see citing works

Alzheimer’s Disease And Type 2 Diabetes: Exploring The Association To Obesity And Tyrosine Hydroxylase

Priyadarshini, M., Kamal, M. A., Greig, N. H., Reale, M., Abuzenadah, A. M., Chaudhary, A., & Damanhouri, G. A. (2012) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152712800792767 · Cited by 44 · see citing works

Lychee seed extract protects against neuronal injury and improves cognitive function in rats with type II diabetes mellitus with cognitive impairment

Tang, Y., Yu, C., Wu, J., Chen, H., Zeng, Y., Wang, X., Yang, L., Mei, Q., Cao, S., & Qin, D. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3245 · Cited by 43 · see citing works

Diabetes mellitus im Alter

Zeyfang, A., Bahrmann, A., & Wernecke, J. (2015) · Diabetologie und Stoffwechsel · doi:10.1055/s-0035-1553883 · Cited by 39 · see citing works

Association between depression and risk of Parkinson's disease in South Korean adults.

Jeong, W., Kim, H., Joo, J., Jang, S., & Park, E.-C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.05.038 · Cited by 36 · see citing works

Mild cognitive impairment in Parkinson disease: heterogenous mechanisms

Jellinger, K. A. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0771-5 · Cited by 37 · see citing works

Quercetin ameliorates chronic unpredicted stress-mediated memory dysfunction in male Swiss albino mice by attenuating insulin resistance and elevating hippocampal GLUT4 levels independent of insulin receptor expression

Mehta, V., Parashar, A., Sharma, A. K., Singh, T. R., & Malairaman, U. (2016) · Hormones and Behavior · doi:10.1016/j.yhbeh.2016.12.012 · Cited by 32 · see citing works

In Silico Investigation of the Pharmacological Mechanisms of Beneficial Effects of Ginkgo biloba L. on Alzheimer’s Disease

Li, H., Sun, X., Yu, F., Xu, L., JianHua, M., & Xiao, P. (2018) · Nutrients · doi:10.3390/nu10050589 · Cited by 30 · see citing works

Burn injury insulin resistance and central nervous system complications: A review

Berlanga‐Acosta, J., Mendoza‐Marí, Y., Rodríguez-Rodríguez, N., Herrera, D. G. D. B., Ojalvo, A. G., Fernández‐Mayola, M., Guillén, G. E., & Valdes-Sosa, P. A. (2020) · Burns Open · doi:10.1016/j.burnso.2020.02.001 · Cited by 22 · see citing works

Different effects of soluble and aggregated amyloid β42 on gene/protein expression and enzyme activity involved in insulin and APP pathways

Bartl, J., Meyer, A. H., Brendler, S., Riederer, P., & Grünblatt, E. (2012) · Journal of Neural Transmission · doi:10.1007/s00702-012-0852-5 · Cited by 19 · see citing works

Telmisartan Treatment Ameliorates Memory Deficits in Streptozotocin-Induced Diabetic Mice via Attenuating Cerebral Amyloidosis

Du, G. T., Hu, M., Mei, Z. L., Wang, C., Liu, G. J., Hu, M. Y., Long, Y., Miao, M. X., Li, J. C., & Hong, H. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.13157fp · Cited by 18 · see citing works

Heterogenous mechanisms of mild cognitive impairment in Parkinson’s disease

Jellinger, K. A. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0716-4 · Cited by 17 · see citing works

Increased expression of β amyloid precursor gene in the hippocampus of streptozotocin-induced diabetic mice with memory deficit and anxiety induction

Jung, S. W., Han, O.-K., & Kim, S.-J. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0516-2 · Cited by 17 · see citing works

Connecting Type 2 diabetes to Alzheimer’s disease

Felice, F. G. D. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.864824 · Cited by 17 · see citing works

Diabetes und Demenz

Bahrmann, A., Bahrmann, P., Kubiak, T., Kopf, D., Oster, P., Sieber, C. C., & Daniel, W. G. (2012) · Zeitschrift für Gerontologie und Geriatrie · doi:10.1007/s00391-011-0269-z · Cited by 16 · see citing works

Contribution of single-minded 2 to hyperglycaemia-induced neurotoxicity

Wang, X., Song, Y., Chen, L., Zhuang, G., Zhang, J., Li, M., & Meng, X. (2013) · NeuroToxicology · doi:10.1016/j.neuro.2013.01.003 · Cited by 12 · see citing works

Assessment and Comparison of Phytochemical Constituents and Biological Activities between Full Flowering and Late Flowering of Hypericum perforatum L.

Piatti, D., Marconi, R., Caprioli, G., Angeloni, S., Ricciutelli, M., Zengin, G., Maggi, F., Pagni, L., & Sagratini, G. (2023) · Applied Sciences · doi:10.3390/app132413304 · Cited by 11 · see citing works

Predictionof Anti-Diabetic Drugs as Dual Inhibitors Against Acetylcholinesterase and Beta-Secretase: A Neuroinformatics Study

Shaikh, S., Rizvi, S. M., Suhail, T., Shakil, S., Abuzenadah, A., Anis, R., Naaz, D., Dallol, A., Haneef, M., Ahmad, A., et al. (2016) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527315666161003125752 · Cited by 10 · see citing works

Experimental Approach to Alzheimer’s Disease with Emphasis on Insulin Resistance in the Brain

Šalković‐Petrišić, M., Perhoč, A. B., Homolak, J., Knezović, A., Barilar, J. O., & Riederer, P. F. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_98-1 · Cited by 9 · see citing works

The Role of Steroidomics in the Diagnosis of Alzheimer’s Disease and Type 2 Diabetes Mellitus

Vaňková, M., Velíková, M., Vejražková, D., Včelák, J., Lukášová, P., Rusina, R., Vankova, H., Jarolímová, E., Kancheva, R., Bulant, J., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108575 · Cited by 7 · see citing works

Experimental Approach to Alzheimer’s Disease with Emphasis on Insulin Resistance in the Brain

Šalković‐Petrišić, M., Perhoč, A. B., Homolak, J., Knezović, A., Barilar, J. O., & Riederer, P. F. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_98 · Cited by 6 · see citing works

Frailty and Parkinson’s disease: the role of diabetes mellitus

Komici, K., Pansini, A., Bencivenga, L., Rengo, G., Pagano, G., & Guerra, G. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1377975 · Cited by 6 · see citing works

Tau Phosphorylation and μ-Calpain Activation Mediate the Dexamethasone-Induced Inhibition on the Insulin-Stimulated Akt Phosphorylation

Liu, Y., Su, Y., Sun, S., Wang, T., Qiao, X., Run, X., & Liang, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035783 · Cited by 6 · see citing works

Disrupted pattern of rich‐club organization in structural brain network from prediabetes to diabetes: A population‐based study

Zhou, Y., Jing, J., Zhang, Z., Pan, Y., Cai, X., Zhu, W., Li, Z., Liu, C., Liu, H., Meng, X., et al. (2024) · Human Brain Mapping · doi:10.1002/hbm.26598 · Cited by 5 · see citing works

A New Perspective on Redefining and Preventing Diabetes to Prevent Dementia in High-Risk Populations

Gadgil, M. A., & Vásquez, E. (2021) · Springer eBooks · doi:10.1007/978-3-030-70119-2_8 · Cited by 2 · see citing works

Disease-Related Variables and Depression Among Iranian Patients with Parkinson Disease

Shakeri, J., Chaghazardi, M., Abdoli, N., Arman, F., Hoseini, S. D., & Shakeri, H. (2015) · Iranian Red Crescent Medical Journal · doi:10.5812/ircmj.30246 · Cited by 2 · see citing works

Diabetes mellitus im Alter

Bahrmann, A., Wernecke, J., Bahrmann, P., Kopf, D., & Zeyfang, A. (2012) · Der Diabetologe · doi:10.1007/s11428-012-0979-x · Cited by 2 · see citing works

Parkinson’s disease and type 2 diabetes mellitus: interrelation of pathogenetic mechanisms and general therapeutic approaches

Troshneva, A. Y., & As, A. (2022) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro202212211212 · Cited by 2 · see citing works

Diabetes mellitus in Parkinson`s disease patients

Ivanov, B., Kaprelyan, A. G., Грудкова, М., Dimitrov, I., & Deleva, N. S. (2013) · Scripta Scientifica Medica · doi:10.14748/ssm.v45i1.346 · Cited by 1 · see citing works

Diabetes mellitus im Alter

Wernecke, J., & Bahrmann, A. (2020) · Geriatrie up2date · doi:10.1055/a-1034-1086 · Cited by 1 · see citing works

Depressive Störungen

Laux, G. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_67 · Cited by 1 · see citing works

Parkinson’s Disease and Type 2 Diabetes Mellitus: Interrelated Pathogenetic Mechanisms and Common Therapeutic Approaches

Troshneva, A. Y., & As, A. (2023) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-023-01488-4 · Cited by 1 · see citing works

Glucose Levels May Predict Depression in Patients With Cardiovascular Diseases

Yılmaz, S., Kuyumcu, M. S., Kuyumcu, A., & Aydoğdu, S. (2015) · Angiology · doi:10.1177/0003319715570962 · Cited by 1 · see citing works

Effects of insulin gene dosage on body weight and glucose homeostasis

Mehran, A. E. (2015) · cIRcle (University of British Columbia) · doi:10.14288/1.0167270

Depressive Störungen

Laux, G. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_67-1

The diabetic parkinsonian – the association of diabetes mellitus comorbidity and symptoms of Parkinson’s disease

Chmiela, T., Węgrzynek-Gallina, J., Wilczek, D., Waksmundski, D., Kasprzyk, A., Cieśla-Fuławka, A., & Gorzkowska, A. (2024) · Aktualności Neurologiczne · doi:10.15557/an.2024.0001

Association of Hemispheric Asymmetry of Dopamine‐Transporter Binding with Risk of Parkinsonian Depression

Fernández‐Espejo, E., & de Fonseca, F. R. (2024) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.14276

Association of cholesterol and glycemic state biomarkers with phenotypic variation and Parkinson's disease progression: The Oxford Discovery cohort

Chiu, N. K. H., Lawton, M., Zerenner, T., Morovat, A., Welch, J., Razzaque, J., Hu, M. T., & Ben‐Shlomo, Y. (2025) · Journal of Parkinson s Disease · doi:10.1177/1877718x251323914

Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus

Joseph, J. J., & Golden, S. H. (2017) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13217 · Cited by 574 · see citing works

A Study on Function of Hypothalamus-pituitary adrenal Axis in Type 2 Diabetic Patients with Depression

Zhi, L. (2003) · Acta Medicinae Sinica

Depression and type 2 diabetes: A causal relationship and mechanistic pathway

Khawagi, W. Y., Al-Kuraishy, H. M., Hussein, N. R., Al-Gareeb, A. I., Atef, E., Elhussieny, O., Alexiou, A. T., Papadakis, M., Jabir, M. S., Alshehri, A. A., et al. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15630 · Cited by 135 · see citing works

Die HPA-Achse als mögliches Bindeglied zwischen Depression, Diabetes mellitus und kognitiven Störungen

Prestele, S., Aldenhoff, J., & Reiff, J. (2003) · Fortschritte der Neurologie · Psychiatrie · doi:10.1055/s-2003-36684 · Cited by 20 · see citing works

Occupational Medicine 2008;58:308 LETTERS TO THE EDITOR

Alexander, A. (2016)